Company: Thermo Fisher Scientific Inc.
Ticker: TMO
Form: 10-K
Filed: 2026-02-26
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Thermo Fisher Scientific Inc.'s operating cash flow margin in fiscal year 2025?
Question Type: derived_ratio

Concept: NetCashProvidedByUsedInOperatingActivities
RevenueFromContractWithCustomerExcludingAssessedTax
Answer (Numeric): 17.55
Answer (Display): 17.55%
Unit: percent

Evidence:
[{"chunk_id": "120", "equivalent_chunk_ids": ["120"], "section": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "supports": ["numerator", "denominator"], "text": "Year Ended\nDecember 31,\n(In millions)\nOperating activities\nNet income\n6,721\n6,338\n5,955\nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation of property, plant and equipment\n1,050\n1,156\n1,068\nAmortization of acquisition-related intangible assets\n1,730\n1,952\n2,338\nChange in deferred income taxes\n1,209\n1,300\nStock-based compensation\nOther net non-cash expenses\nChanges in assets and liabilities, excluding the effects of acquisitions:\nAccounts receivable\nInventories\nContract assets/liabilities\nAccounts payable\nContributions to retirement plans\nOther\n1,312\nNet cash provided by operating activities\n7,818\n8,667\n8,406\nInvesting activities\nPurchases of property, plant and equipment\n1,525\n1,400\n1,479\nProceeds from sale of property, plant and equipment\nProceeds from cross-currency interest rate swap interest settlements\nAcquisitions, net of cash acquired\n4,037\n3,132\n3,660\nPurchases of investments\n3,396\nProceeds from sales and maturities of investments\n1,565\n1,770\nOther investing activities, net\nNet cash used in investing activities\n4,047\n5,841\n5,142\nFinancing activities\nNet proceeds from issuance of debt\n7,759\n1,204\n5,942\nRepayment of debt\n2,412\n3,607\n5,782\nProceeds from issuance of commercial paper\n1,095\n1,620\nRepayments of commercial paper\n1,095\n1,935\nPurchases of company common stock\n3,000\n4,000\n3,000\nDividends paid\nOther financing activities, net\nNet cash provided by/(used in) financing activities\n1,801\n6,792\n3,622\nExchange rate effect on cash\nIncrease/(decrease) in cash, cash equivalents and restricted cash\n5,839\n4,057\nCash, cash equivalents and restricted cash at beginning of year\n4,040\n8,097\n8,537\nCash, cash equivalents and restricted cash at end of year\n9,879\n4,040\n8,097\nThe accompanying notes are an integral part of these consolidated financial statements.\nTHERMO FISHER SCIENTIFIC INC."}]

Derivation: {"denominator": "revenue", "denominator_value": 44556.0, "format": "percentage", "numerator": "operating_cash_flow", "numerator_value": 7818.0, "op": "divide"}